Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Randomized controlled trial validates total hip arthroplasty for improving functional capacity

4

May 2026

Randomized controlled trial validates total hip arthroplasty for improving functional capacity

Total hip arthroplasty leads to the best outcomes in the treatment of moderate-to-severe hip osteoarthritis, according to a new study by the University of Eastern Finland and Kuopio University Hospital. During a one-year follow-up, surgery combined with conservative treatment was found to relieve pain and improve functional capacity and quality of life more effectively than conservative treatment alone, which was based on an exercise program.

Researchers leverage tamoxifen's active metabolite to improve breast cancer prevention

4

May 2026

Researchers leverage tamoxifen's active metabolite to improve breast cancer prevention

Low doses of the investigational medicinal product endoxifen reduce breast density to the same extent as the standard treatment tamoxifen, but without causing such troublesome side effects. This is shown by a new study from Karolinska Institutet published in the Journal of the National Cancer Institute. The results may have implications for future preventive treatment of breast cancer.

65 % of eligible lung cancer patients do not receive the most appropriate targeted therapies, Diaceutics report finds

4

May 2026

65 % of eligible lung cancer patients do not receive the most appropriate targeted therapies, Diaceutics report finds

Diaceutics, the intelligence and engagement company unlocking the full potential of diagnostic-driven therapies, has released new research revealing a critical shift in precision medicine. Despite major advances in biomarker testing, nearly two-thirds of eligible patients with advanced non-small cell lung cancer (aNSCLC) in the US are still not receiving the most appropriate treatment

AAD survey reveals Americans ignore sun risks despite skin cancer concerns

4

May 2026

AAD survey reveals Americans ignore sun risks despite skin cancer concerns

The American Academy of Dermatology (AAD) today released results from its annual Practice Safe Sun Survey, revealing many Americans still engage in risky sun behaviors driven by misinformation, social media, and persistent tanning myths despite their concerns about the long term aging effects of sun exposure. In recognition of Skin Cancer Awareness Month (May) and Melanoma Monday® on May 4, the AAD is encouraging the public to practice safe sun to reduce their risk of skin cancer.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.